Product Information

ATORVASTATIN 20 MG TABLET is a generic product labeled by AvPAK, priced at $0.0286 per EA under NDC 50268009415. Its NADAC has been published 470 times since Nov 15, 2017.

FDA first approved this application on May 29, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATORVASTATIN 20 MG TABLET

ATORVASTATIN CALCIUM
$0.0286per EA

Strength

20 mg/1

Manufacturer

AvPAK

NDC

50268009415

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090548

FDA Approved

5/29/2012

TE Code

AB

On Market Since

6/28/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 20 MG TABLET has been published 470 times since Nov 15, 2017, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0286 per EA
All-time high$0.1036 (Nov 15, 2017)
All-time low$0.0276 (Aug 19, 2026)
52-week high$0.0310
52-week low$0.0276
Median price$0.0475
Average price$0.0533
Largest weekly change+32.4% (Aug 21, 2024)
Weeks tracked470
Tracking sinceNov 15, 2017

Price History

1W

0.0%

1M

+2.4%

3M

+2.3%

6M

-0.5%

1Y

-7.7%

3Y

-23.9%

5Y

-50.2%

All

-72.4%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by AvPAK, is $0.0286 per EA (NDC 50268009415), effective Nov 11, 2026.

How has the price of ATORVASTATIN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 72.4%. It has been tracked across 470 weekly CMS publications since Nov 15, 2017.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?

Since Nov 15, 2017, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0276 (Aug 19, 2026) to a high of $0.1036 (Nov 15, 2017), with a median of $0.0475 per EA.

Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 20 MG TABLET, is $0.0285 per EA — about 0% below ATORVASTATIN 20 MG TABLET.

Who manufactures ATORVASTATIN 20 MG TABLET?

ATORVASTATIN 20 MG TABLET (NDC 50268009415) is labeled by AvPAK, and CMS classifies it as a generic product.